Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Total 13F shares
-
2,379,706
-
Share change
-
+2,379,706
-
Total reported value
-
$62,898,000
-
Price per share
-
$26.43
-
Number of holders
-
11
-
Value change
-
+$62,897,992
-
Number of buys
-
11
Institutional Holders of HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) as of Q1 2019
As of 31 Mar 2019,
HORIZON THERAPEUTICS PLC - COMMON STOCK-FO (HZNP) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,379,706 shares.
The largest 10 holders included
PANAGORA ASSET MANAGEMENT INC, Marshall Wace North America L.P., Tudor Investment Corp Et Al, SEGALL BRYANT & HAMILL, LLC, GLOBEFLEX CAPITAL L P, Hillsdale Investment Management Inc., MARSHALL WACE, LLP, Campbell & CO Investment Adviser LLC, CAPTRUST FINANCIAL ADVISORS, and Advisory Services Network, LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.